Healthcare -
Biotechnology - NASDAQ - US
$ 16.5
0.671 %
$ 3.9 B
Market Cap
61.11
P/E
ADMA - COST OF REVENUE
Cost of Revenue ADMA - ADMA Biologics, Inc.
169 M
LAST VALUE
45.67%
2 YEAR CAGR
32.03%
5 YEAR CAGR
55.69%
10 YEAR CAGR